-
OBCI Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Ocean Bio Chem (OBCI)
Company Profile
Quarter (USD) | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 7.02 mm | 7.02 mm | 7.02 mm | 7.02 mm | 7.02 mm | 7.02 mm |
Cash burn (monthly) | 1.07 mm | 107.19 k | 136.17 k | (no burn) | 1.66 mm | 17.20 k |
Cash used (since last report) | 35.07 mm | 3.53 mm | 4.48 mm | n/a | 54.70 mm | 565.77 k |
Cash remaining | -28.05 mm | 3.49 mm | 2.54 mm | n/a | -47.69 mm | 6.45 mm |
Runway (months of cash) | -26.3 | 32.6 | 18.7 | n/a | -28.7 | 375.1 |
13F holders | Current |
---|---|
Total holders | 17 |
Opened positions | 0 |
Closed positions | 3 |
Increased positions | 3 |
Reduced positions | 5 |
13F shares | Current |
---|---|
Total value | 17.95 mm |
Total shares | 1.80 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Veradace Capital Management | 713.93 k | $7.50 mm |
Hirschman Orin | 373.16 k | $4.66 mm |
Renaissance Technologies | 221.70 k | $1.81 mm |
Vanguard | 155.54 k | $1.27 mm |
AltraVue Capital | 127.95 k | $1.04 mm |
Dimensional Fund Advisors | 79.47 k | $641.00 k |
SF Stifel Financial | 30.72 k | $251.00 k |
Geode Capital Management | 28.52 k | $230.00 k |
Ancora Advisors | 14.89 k | $121.00 k |
James Investment Research | 14.05 k | $115.00 k |